Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 16, 2025Endocrine Metabolic & Immune Disorders - Drug Targets

Humanized Immune Mouse Models: Emerging Applications for Cancer Immunotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

YZYu-Sen ZhongWXWei XieXLXuejian Li

Discussion

Loading...

Member takes

Overview

This article discusses the use of humanized immune mouse models in cancer immunotherapy, highlighting SCID mice and their benefits.

Key Points

  • Humanized immune mouse models enable better evaluation of immunotherapies in cancer research, improving relevance to human health.
  • SCID mice engrafted with human immune cells show enhanced human-like immune responses, aiding in immuno-oncology studies.
  • Research highlights both advancements and limitations, including challenges like graft-versus-host disease in these models.
  • These models facilitate investigations of tumor growth and the effectiveness of human-specific cancer treatments.

Cite This Study

Zhong et al. (2025) studied this question.

synapsesocial.com/papers/68d44f8331b076d99fa57232https://doi.org/10.2174/0118715303382108250825062059
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Abstract 3380: Enhancing preclinical insights in immuno-oncology with humanized mice2026
  2. 2Humanized Mouse Models of Clinical Disease2016 · 565 citations
  3. 3Abstract 85: Immunomics of immune-deficient mouse models before and after CD34 humanization2024
  4. 4Abstract 714: Enhanced in vivo and ex vivo analysis enables deeper characterization of humanized mouse models for immuno-oncology research.2026
  5. 5MHC class I and II-deficient humanized mice are suitable tools to test the long-term antitumor efficacy of immune checkpoint inhibitors and T-cell engagers2024 · 12 citations